Mawer Investment Management Ltd. lowered its holdings in shares of Accenture plc (NYSE:ACN – Free Report) by 2.2% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 824,545 shares of the information technology services provider’s stock after selling 18,785 shares during the period. Accenture comprises 1.3% of Mawer Investment Management Ltd.’s portfolio, making the stock its 23rd largest holding. Mawer Investment Management Ltd. owned approximately 0.13% of Accenture worth $290,067,000 at the end of the most recent quarter.
Other hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in Accenture in the fourth quarter valued at about $2,351,683,000. Raymond James Financial Inc. bought a new stake in shares of Accenture in the 4th quarter valued at approximately $666,495,000. Swedbank AB raised its holdings in shares of Accenture by 47.5% in the 4th quarter. Swedbank AB now owns 3,763,690 shares of the information technology services provider’s stock worth $1,324,029,000 after buying an additional 1,212,011 shares in the last quarter. Proficio Capital Partners LLC boosted its stake in Accenture by 51,837.3% in the 4th quarter. Proficio Capital Partners LLC now owns 860,601 shares of the information technology services provider’s stock valued at $302,751,000 after buying an additional 858,944 shares in the last quarter. Finally, Amundi grew its position in Accenture by 27.9% in the fourth quarter. Amundi now owns 3,790,069 shares of the information technology services provider’s stock valued at $1,353,909,000 after acquiring an additional 826,038 shares during the period. Institutional investors and hedge funds own 75.14% of the company’s stock.
Accenture Stock Performance
Shares of Accenture stock opened at $304.32 on Friday. Accenture plc has a 52 week low of $278.69 and a 52 week high of $398.35. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.47 and a current ratio of 1.47. The stock has a market capitalization of $190.61 billion, a price-to-earnings ratio of 25.53, a PEG ratio of 3.23 and a beta of 1.24. The firm has a fifty day moving average of $354.96 and a two-hundred day moving average of $356.03.
Accenture Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Thursday, April 10th will be paid a $1.48 dividend. This represents a $5.92 annualized dividend and a yield of 1.95%. The ex-dividend date of this dividend is Thursday, April 10th. Accenture’s payout ratio is presently 48.89%.
Insider Transactions at Accenture
In other Accenture news, CFO Angie Y. Park sold 685 shares of the stock in a transaction dated Friday, January 17th. The stock was sold at an average price of $354.38, for a total transaction of $242,750.30. Following the completion of the transaction, the chief financial officer now owns 8,674 shares in the company, valued at approximately $3,073,892.12. This represents a 7.32 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Julie Spellman Sweet sold 8,793 shares of the business’s stock in a transaction dated Wednesday, February 5th. The shares were sold at an average price of $394.47, for a total value of $3,468,574.71. Following the completion of the sale, the chief executive officer now owns 11,858 shares in the company, valued at approximately $4,677,625.26. This trade represents a 42.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 21,905 shares of company stock valued at $8,181,753 over the last three months. 0.02% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
Several research firms have recently weighed in on ACN. Jefferies Financial Group lowered their target price on shares of Accenture from $385.00 to $355.00 and set a “hold” rating on the stock in a report on Tuesday, January 21st. Guggenheim decreased their price objective on shares of Accenture from $400.00 to $395.00 and set a “buy” rating on the stock in a research note on Friday, March 21st. Barclays cut their target price on shares of Accenture from $415.00 to $390.00 and set an “overweight” rating for the company in a research note on Monday, March 24th. Morgan Stanley dropped their price target on Accenture from $380.00 to $372.00 and set an “equal weight” rating for the company in a report on Monday, March 17th. Finally, Stifel Nicolaus reduced their price objective on Accenture from $390.00 to $380.00 and set a “buy” rating on the stock in a research note on Wednesday, February 26th. Eight equities research analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, Accenture has a consensus rating of “Moderate Buy” and an average target price of $378.23.
About Accenture
Accenture plc, a professional services company, provides strategy and consulting, industry X, song, and technology and operation services worldwide. The company offers application services, including agile transformation, DevOps, application modernization, enterprise architecture, software and quality engineering, data management; intelligent automation comprising robotic process automation, natural language processing, and virtual agents; and application management services, as well as software engineering services; strategy and consulting services; data and analytics strategy, data discovery and augmentation, data management and beyond, data democratization, and industrialized solutions comprising turnkey analytics and artificial intelligence (AI) solutions; metaverse; and sustainability services.
Featured Articles
- Five stocks we like better than Accenture
- What is a SEC Filing?
- MarketBeat Week in Review – 03/24 – 03/28
- Do ETFs Pay Dividends? What You Need to Know
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- What is a support level?
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Accenture Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accenture and related companies with MarketBeat.com's FREE daily email newsletter.